Immigrants who say their detention is illegal have filed more than 18,000 cases. It’s...
The number of immigrants held in detention has increased from around 40,000 when Trump took office to more than 70,000 this year.
Detroit’s death spiral?
How Trump’s climate policy could kill the U.S. auto industry.
Israeli MP Galit Distel Atbaryan advocates for erasing Gaza, raising alarm
An Israeli Member of Parliament's statement advocating for Gaza to be "erased from the face of the earth" raises alarm and highlights the intensifying rhetoric in the region.
America’s new Industrial Revolution
Will Donald Trump will be remembered ruefully as our country’s very own King Canute, who used the full force of presidential power in a failed, futile effort to halt the tides of technological change?
Native American voters get boost in North Dakota
After a lengthy legal fight, state and tribal officials reach settlement over ID law
Does Brazil have an app that can upend digital finance?
Washington’s unease is rising as Brazil’s Pix bypasses U.S.-dominated payment networks. The country’s digital payment revolution may soon be impossible to contain as other countries adapt their own models.
Civil rights groups sue HHS over records tied to $10 billion childcare funding freeze
Advocates say the Trump administration must disclose how disputed fraud allegations involving Somali childcare providers became the basis for sweeping restrictions on federal aid.
Judge blocks ICE retaliation in Minnesota as protests escalate and federal force looms
A federal injunction curbing ICE conduct follows the killing of a legal observer, mounting allegations of constitutional violations, and threats of military deployment under Trump’s immigration crackdown.
US declines to protect endangered monkeys used in medical research
The U.S. has again declined to protect endangered long-tailed macaques under the Endangered Species Act, allowing continued imports for biomedical research.
Psychedelic drug in clinical trial to help stroke victims recover by rewiring brain
Algernon Pharmaceuticals, a Canadian-based company, began its study this week in which stroke participants will be given a microdose of DMT with the hope of minimizing damage and maximizing recovery.